Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease

174Citations
Citations of this article
328Readers
Mendeley users who have this article in their library.

Abstract

Background: Interstitial lung disease (ILD) is one of the leading causes of mortality in patients with systemic sclerosis (SSc). To further understand this patient population, we present the first systematic review on the epidemiology of SSc and SSc-associated ILD (SSc-ILD). Methods: Bibliographic databases and web sources were searched for studies including patients with SSc and SSc-ILD in Europe and North America (United States and Canada). The systematic review was limited to publications in English, German, French, Spanish, Italian, and Portuguese, published between January 1, 2000 and February 29, 2016. For all publications included in the review, the methodologic quality was assessed. For each dimension and region, data availability in terms of quantity and consistency of reported findings was evaluated. Results: Fifty publications reporting epidemiologic data (prevalence, incidence, demographic profile, and survival and mortality) were included; 39 included patients with SSc and 16 included patients with SSc-ILD. The reported prevalence of SSc was 7.2-33.9 and 13.5-44.3 per 100,000 individuals in Europe and North America, respectively. Annual incidence estimates were 0.6-2.3 and 1.4-5.6 per 100,000 individuals in Europe and North America, respectively. Associated ILD was present in ~35% of the patients in Europe and ~52% of the patients in North America. In Europe, a study estimated the prevalence and annual incidence of SSc-ILD at 1.7-4.2 and 0.1-0.4 per 100,000 individuals, respectively. In both Europe and North America, SSc-ILD was diagnosed at a slightly older age than SSc, with both presentations of the disease affecting 2-3 times more women than men. Ten-year survival in patients with SSc was reported at 65-73% in Europe and 54-82% in North America, with cardiorespiratory manifestations (including ILD) associated with poor prognosis. Conclusion: This systematic review confirms that SSc and SSc-ILD are rare, with geographic variation in prevalence and incidence.

References Powered by Scopus

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

5083Citations
N/AReaders
Get full text

2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

2542Citations
N/AReaders
Get full text

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I

1888Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Systemic sclerosis

228Citations
N/AReaders
Get full text

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease

72Citations
N/AReaders
Get full text

Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey

67Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bergamasco, A., Hartmann, N., Wallace, L., & Verpillat, P. (2019). Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease. Clinical Epidemiology, 11, 257–273. https://doi.org/10.2147/CLEP.S191418

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 79

68%

Researcher 26

22%

Professor / Associate Prof. 7

6%

Lecturer / Post doc 5

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 87

61%

Biochemistry, Genetics and Molecular Bi... 29

20%

Immunology and Microbiology 14

10%

Pharmacology, Toxicology and Pharmaceut... 13

9%

Article Metrics

Tooltip
Mentions
News Mentions: 1
References: 1
Social Media
Shares, Likes & Comments: 29

Save time finding and organizing research with Mendeley

Sign up for free